Third-Generation Neuroimaging: Translating Research into Clinical Utility

Psychiatric imaging needs to move away from simple investigations of the neurobiology underling the early phases of psychiatric diseases to translate imaging findings in the clinical field targeting clinical outcomes including transition, remission and response to preventative interventions. This re...

Full description

Saved in:
Bibliographic Details
Superior document:Frontiers Research Topics
:
Year of Publication:2016
Language:English
Series:Frontiers Research Topics
Physical Description:1 electronic resource (224 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993541017504498
ctrlnum (CKB)4100000002484629
(oapen)https://directory.doabooks.org/handle/20.500.12854/60896
(EXLCZ)994100000002484629
collection bib_alma
record_format marc
spelling Andre Schmidt auth
Third-Generation Neuroimaging: Translating Research into Clinical Utility
Third-Generation Neuroimaging
Frontiers Media SA 2016
1 electronic resource (224 p.)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Frontiers Research Topics
Psychiatric imaging needs to move away from simple investigations of the neurobiology underling the early phases of psychiatric diseases to translate imaging findings in the clinical field targeting clinical outcomes including transition, remission and response to preventative interventions. This research topic aims to bring psychiatric neuroimaging studies towards translational impacts in clinical practice, suggesting that brain abnormalities may be of potential use for detecting clinical outcomes as treatment response. First-generation psychiatric neuroimaging focused on simple structural brain alterations associated with the neurobiology of the illness. These early studies adopted imaging methods mainly including computerized tomography (CT) to investigate brain size. Second-generation psychiatric neuroimaging studies benefited from more sophisticated techniques which included structural methods (sMRI) coupled with whole-brain automated methods (voxel based morphometry, VBM), white-matter methods (diffusion tensor imaging, DTI and tractography), functional methods (functional magnetic resonance imaging, fMRI) and advanced neurochemical imaging (PET techniques addressing receptor bindings and pre/post synaptic functions, magnetic resonance spectroscopy, MRS) and sophisticated meta-analytical imaging methods. However, no consistent or reliable anatomical or functional brain alterations have been univocally associated with any psychiatric disorder and no clinical applications have been developed in psychiatric neuroimaging. There is thus urgent need of psychiatric imaging to move towards third-generation paradigms. In this research topic, these novel neuroimaging studies here requested to move away from simple investigations of the neurobiology to translate imaging findings in the clinical field targeting longitudinal outcomes including transition, remission and response to preventative interventions. With respect to methods, the most recent neuroimaging approaches (e.g. structural and functional MRI, EEG, DTI, spectroscopy, PET) are welcome. Third generation psychiatric imaging studies including multimodal approaches, multi-center analyses, mega-analyses, effective connectivity, dynamic causal modelling, support vector machines, structural equation modelling, or graph theory analysis are highly appreciated. Furthermore, these third-generation imaging studies may benefit from the incorporation of new sources of neurobiological information such as whole genome sequencing, proteomic, lipidomic and expression profiles and cellular models derived from recent induced pluripotent stem cells research. We collect Original Research, Reviews, Mini-Reviews, Book Review, Clinical Case Study, Clinical Trial, Editorial, General Commentary, Hypothesis & Theory, Methods, Mini Opinion, Perspective, and Technology Report from international researcher and clinicians in this field. The purpose of this research topic is intended to provide the field with current third-generation neuroimaging approaches in translational psychiatry that is hoped to improve and create therapeutic options for psychiatric diseases.
English
Neuroimaging
clinical outcomes
translational psychiatry
clinical utility
remission
Transition
prediction
Psychiatry
2-88945-044-9
Stefan Borgwardt auth
language English
format eBook
author Andre Schmidt
spellingShingle Andre Schmidt
Third-Generation Neuroimaging: Translating Research into Clinical Utility
Frontiers Research Topics
author_facet Andre Schmidt
Stefan Borgwardt
author_variant a s as
author2 Stefan Borgwardt
author2_variant s b sb
author_sort Andre Schmidt
title Third-Generation Neuroimaging: Translating Research into Clinical Utility
title_full Third-Generation Neuroimaging: Translating Research into Clinical Utility
title_fullStr Third-Generation Neuroimaging: Translating Research into Clinical Utility
title_full_unstemmed Third-Generation Neuroimaging: Translating Research into Clinical Utility
title_auth Third-Generation Neuroimaging: Translating Research into Clinical Utility
title_alt Third-Generation Neuroimaging
title_new Third-Generation Neuroimaging: Translating Research into Clinical Utility
title_sort third-generation neuroimaging: translating research into clinical utility
series Frontiers Research Topics
series2 Frontiers Research Topics
publisher Frontiers Media SA
publishDate 2016
physical 1 electronic resource (224 p.)
isbn 2-88945-044-9
illustrated Not Illustrated
work_keys_str_mv AT andreschmidt thirdgenerationneuroimagingtranslatingresearchintoclinicalutility
AT stefanborgwardt thirdgenerationneuroimagingtranslatingresearchintoclinicalutility
AT andreschmidt thirdgenerationneuroimaging
AT stefanborgwardt thirdgenerationneuroimaging
status_str n
ids_txt_mv (CKB)4100000002484629
(oapen)https://directory.doabooks.org/handle/20.500.12854/60896
(EXLCZ)994100000002484629
carrierType_str_mv cr
hierarchy_parent_title Frontiers Research Topics
is_hierarchy_title Third-Generation Neuroimaging: Translating Research into Clinical Utility
container_title Frontiers Research Topics
author2_original_writing_str_mv noLinkedField
_version_ 1787548496108191744
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04282nam-a2200385z--4500</leader><controlfield tag="001">993541017504498</controlfield><controlfield tag="005">20231214133402.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202102s2016 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4100000002484629</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/60896</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994100000002484629</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Andre Schmidt</subfield><subfield code="4">auth</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Third-Generation Neuroimaging: Translating Research into Clinical Utility</subfield></datafield><datafield tag="246" ind1=" " ind2=" "><subfield code="a">Third-Generation Neuroimaging</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">Frontiers Media SA</subfield><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (224 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Frontiers Research Topics</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Psychiatric imaging needs to move away from simple investigations of the neurobiology underling the early phases of psychiatric diseases to translate imaging findings in the clinical field targeting clinical outcomes including transition, remission and response to preventative interventions. This research topic aims to bring psychiatric neuroimaging studies towards translational impacts in clinical practice, suggesting that brain abnormalities may be of potential use for detecting clinical outcomes as treatment response. First-generation psychiatric neuroimaging focused on simple structural brain alterations associated with the neurobiology of the illness. These early studies adopted imaging methods mainly including computerized tomography (CT) to investigate brain size. Second-generation psychiatric neuroimaging studies benefited from more sophisticated techniques which included structural methods (sMRI) coupled with whole-brain automated methods (voxel based morphometry, VBM), white-matter methods (diffusion tensor imaging, DTI and tractography), functional methods (functional magnetic resonance imaging, fMRI) and advanced neurochemical imaging (PET techniques addressing receptor bindings and pre/post synaptic functions, magnetic resonance spectroscopy, MRS) and sophisticated meta-analytical imaging methods. However, no consistent or reliable anatomical or functional brain alterations have been univocally associated with any psychiatric disorder and no clinical applications have been developed in psychiatric neuroimaging. There is thus urgent need of psychiatric imaging to move towards third-generation paradigms. In this research topic, these novel neuroimaging studies here requested to move away from simple investigations of the neurobiology to translate imaging findings in the clinical field targeting longitudinal outcomes including transition, remission and response to preventative interventions. With respect to methods, the most recent neuroimaging approaches (e.g. structural and functional MRI, EEG, DTI, spectroscopy, PET) are welcome. Third generation psychiatric imaging studies including multimodal approaches, multi-center analyses, mega-analyses, effective connectivity, dynamic causal modelling, support vector machines, structural equation modelling, or graph theory analysis are highly appreciated. Furthermore, these third-generation imaging studies may benefit from the incorporation of new sources of neurobiological information such as whole genome sequencing, proteomic, lipidomic and expression profiles and cellular models derived from recent induced pluripotent stem cells research. We collect Original Research, Reviews, Mini-Reviews, Book Review, Clinical Case Study, Clinical Trial, Editorial, General Commentary, Hypothesis &amp; Theory, Methods, Mini Opinion, Perspective, and Technology Report from international researcher and clinicians in this field. The purpose of this research topic is intended to provide the field with current third-generation neuroimaging approaches in translational psychiatry that is hoped to improve and create therapeutic options for psychiatric diseases.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Neuroimaging</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">clinical outcomes</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">translational psychiatry</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">clinical utility</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">remission</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Transition</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">prediction</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Psychiatry</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">2-88945-044-9</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Stefan Borgwardt</subfield><subfield code="4">auth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:52:36 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2018-03-10 17:16:05 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5337347850004498&amp;Force_direct=true</subfield><subfield code="Z">5337347850004498</subfield><subfield code="b">Available</subfield><subfield code="8">5337347850004498</subfield></datafield></record></collection>